Paper766720
Postpsychotic depression in schizophrenia.
McGlashan TH and 1 other. Arch Gen Psychiatry, 1976. Cited by 275 papers, by iCite.
Cite this record
ConductScience Library. Postpsychotic depression in schizophrenia. Papers, record 766720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/766720
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Depression | Major topic |
| Schizophrenia | Major topic |
| Affect | |
| Diagnosis, Differential | |
| Humans | |
| Prognosis | |
| Psychotherapy | |
| Schizophrenic Psychology | |
| Terminology as Topic | |
| Thinking |
Source PubMed
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 275 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42095058 | A systematic review investigating the relationship between green and blue spaces and depression in older adults via DNA methylation. | Environ Epigenet | 2026 | https://conductscience.org/library/papers/42095058 | PubMed |
| 42041642 | Post-Psychotic Depression: A Comprehensive Narrative Review. | Diseases | 2026 | https://conductscience.org/library/papers/42041642 | PubMed |
| 41233335 | Depressive symptomatology in the first-episode schizophrenia spectrum disorders OPTiMiSE trial: prevalence, correlates, symptom progression and outcomes. | Schizophrenia (Heidelb) | 2025 | https://conductscience.org/library/papers/41233335 | PubMed |
| 39006901 | Diagnosis and treatment depression in schizophrenia. | Consort Psychiatr | 2020 | https://conductscience.org/library/papers/39006901 | PubMed |
| 37644044 | Identifying the mediating role of socioeconomic status on the relationship between schizophrenia and major depressive disorder: a Mendelian randomisation analysis. | Schizophrenia (Heidelb) | 2023 | https://conductscience.org/library/papers/37644044 | PubMed |
| 36482878 | A case of postpsychotic depression improved by switching antipsychotic monotherapy. | Neuropsychopharmacol Rep | 2023 | https://conductscience.org/library/papers/36482878 | PubMed |
| 35328011 | Genetic Predisposition to Schizophrenia and Depressive Disorder Comorbidity. | Genes (Basel) | 2022 | https://conductscience.org/library/papers/35328011 | PubMed |
| 33151310 | Antidepressive Effect of Antipsychotics in the Treatment of Schizophrenia: Meta-Regression Analysis of Randomized Placebo-Controlled Trials. | Int J Neuropsychopharmacol | 2021 | https://conductscience.org/library/papers/33151310 | PubMed |
| 32581869 | Psychiatric Diagnoses and Treatment Preceding Schizophrenia in Adolescents Aged 9-17 Years. | Front Psychiatry | 2020 | https://conductscience.org/library/papers/32581869 | PubMed |
| 32246196 | A 2-year longitudinal study of neuropsychological functioning, psychosocial adjustment and rehospitalisation in schizophrenia and major depression. | Eur Arch Psychiatry Clin Neurosci | 2020 | https://conductscience.org/library/papers/32246196 | PubMed |
| 31477079 | Subjective quality of life among patients with schizophrenia spectrum disorder and patients with major depressive disorder. | BMC Psychiatry | 2019 | https://conductscience.org/library/papers/31477079 | PubMed |
| 27069064 | The "Insight Paradox" in Schizophrenia: Magnitude, Moderators and Mediators of the Association Between Insight and Depression. | Schizophr Bull | 2016 | https://conductscience.org/library/papers/27069064 | PubMed |
| 26970100 | The Role of Insight in Moderating the Association Between Depressive Symptoms in People With Schizophrenia and Stigma Among Their Nearest Relatives: A Pilot Study. | Schizophr Bull | 2016 | https://conductscience.org/library/papers/26970100 | PubMed |
| 25834445 | Augmentation with antidepressants in schizophrenia treatment: benefit or risk. | Neuropsychiatr Dis Treat | 2015 | https://conductscience.org/library/papers/25834445 | PubMed |
| 25762938 | Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models. | Front Psychiatry | 2015 | https://conductscience.org/library/papers/25762938 | PubMed |
| 25171855 | Testing trait depression as a potential clinical domain in schizophrenia. | Schizophr Res | 2014 | https://conductscience.org/library/papers/25171855 | PubMed |
| 25055980 | The effects of aging on insight into illness in schizophrenia: a review. | Int J Geriatr Psychiatry | 2014 | https://conductscience.org/library/papers/25055980 | PubMed |
| 23734941 | Metacognitive awareness of cognitive problems in schizophrenia: exploring the role of symptoms and self-esteem. | Psychol Med | 2014 | https://conductscience.org/library/papers/23734941 | PubMed |
| 22661807 | Schizophrenia - insight, depression: a correlation study. | Indian J Psychol Med | 2012 | https://conductscience.org/library/papers/22661807 | PubMed |
| 22058481 | Post-psychotic depression in schizophrenics: (a prospective study). | Indian J Psychiatry | 1980 | https://conductscience.org/library/papers/22058481 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/766720
GET https://conductscience.org/api/papers/v1/766720/cited_by?page=2